COVELLA PHARMACEUTICALS

Covella Pharmaceuticals

#People #More

COVELLA PHARMACEUTICALS

Industry:
Biotechnology

Status:
Active


Founder


lawrence-fritz_image

Lawrence Fritz

More informations about "Covella Pharmaceuticals"

Covella Pharmaceuticals - Crunchbase Company Profile & Funding

Sub-Organization of . Salix Pharmaceuticals . Founders Lawrence Fritz; Operating Status Active; Company Type For Profit; ... Alternatives and possible competitors to Covella Pharmaceuticals …See details»

Covella Pharmaceuticals - PitchBook

Covella Pharmaceuticals was acquired on 10-Sep-2010. Who acquired Covella Pharmaceuticals? Covella Pharmaceuticals was acquired by Santarus. Data Transparency. Meet our data …See details»

AGREEMENT AND PLAN OF MERGER by and among SANTARUS, …

AGREEMENT AND PLAN OF MERGER by and among SANTARUS, INC., SAN ACQUISITION CORP., COVELLA PHARMACEUTICALS, INC. and LAWRENCE C. FRITZ as the …See details»

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

SAN DIEGO, Sep 13, 2010 (BUSINESS WIRE) -- --Acquires Worldwide Rights for Anti-VLA-1 Antibody Through Acquisition of Covella Pharmaceuticals --Conference Call with …See details»

Covella Pharmaceuticals Inc - Company Profile and News

Company profile page for Covella Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

COVELLA PHARMACEUTICALS, INC. :: California (US)

Free and open company data on California (US) company COVELLA PHARMACEUTICALS, INC. (company number 3281180), 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 …See details»

Covella Pharmaceuticals Inc Company Profile, Financial and

As of September 10, 2010, Covella Pharmaceuticals, Inc. operates as a subsidiary of Santarus Inc. digitGaps report on Covella Pharmaceuticals Inc delivers a detailed in-depth and …See details»

Covella Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

100 Translational Medicine associated with Covella Pharmaceuticals, Inc. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»

Covella Pharmaceuticals, Inc. in San Diego CA - Company Profile

Covella Pharmaceuticals, Inc. Overview. Covella Pharmaceuticals, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California and is no longer active.This …See details»

COVELLA PHARMACEUTICALS, INC. in Wilmington, DE | Company …

Feb 17, 2025 COVELLA PHARMACEUTICALS, INC. is a Delaware Corporation filed on December 6, 2007. The company's File Number is listed as 4469427 . The Registered Agent …See details»

Life Sciences Entrepreneur - Forbes

Mar 26, 2009 Dr. Larry Fritz has founded and developed several successful biotechnology companies. His most recent company, Covella Pharmaceuticals, is focused on new …See details»

e8vk - SEC.gov

Of Incorporation or Organization) 0-50651 (Commission File Number) 33-0734433 (I.R.S. Employer ... acquired the worldwide rights to a humanized anti-VLA-1 antibody through the …See details»

COVELLA PHARMACEUTICALS, INC. - Bizapedia

COVELLA PHARMACEUTICALS, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 8510 Colonnade Center Drive Raleigh, NC 27615: …See details»

Lawrence Fritz - Executive Chairman, Co-Founder - Crunchbase

Prior to joining Auspex he was Founder, President and CEO of Covella Pharmaceuticals, a company focused on inflammatory diseases. Covella was acquired in 2010 by Santarus, Inc. …See details»

Covella Pharmaceuticals (Covella Pharmaceuticals) - 药物管线_专 …

了解Covella Pharmaceuticals (Covella Pharmaceuticals)公司的药物管线,治疗领域,技术平台,以及它的。See details»

Larry Fritz, presidente y consejero delegado de Covella …

Oct 15, 2010 Medio: Negocios en Navarra Larry Fritz, presidente y consejero delegado de Covella Pharmaceuticals Inc., empresa que investiga nuevos mecanismos para tratar …See details»

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

Sep 13, 2010 Santarus also has acquired the worldwide rights to a novel biologic drug candidate, an anti-VLA-1 antibody that has shown activity in multiple preclinical models of …See details»

SEC.gov

Organization and Business. Santarus, Inc. (“Santarus” or the “Company”) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary …See details»

Covella Pharmaceuticals, Inc.: 药物管线_专利_临床试验_投融营收

了解Covella Pharmaceuticals, Inc.公司的药物管线,治疗领域,技术平台,以及它的。See details»

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

Sep 14, 2010 Acquires Worldwide Rights for Anti-VLA-1 Antibody Through Acquisition of Covella Pharmaceuticals Conference Call with Accompanying Slide Presentation to Begin at 9:00 a.m. …See details»